logo
Plus   Neg
Share
Email

INPP Reaffirms Operational Performance Of Investment Portfolio Continues

International Public Partnership Lid (INPP.L) reaffirmed that the operational performance of its investment portfolio continues.

The Covid-19 pandemic has, to date, had no material impact on the Company's cashflow from its investment portfolio. However, the company noted that the Covid-19 pandemic is unprecedented and its full impact on the Company over time cannot be ascertained at this time.

The company noted that there are a range of contingent risks stemming from the Covid-19 pandemic. These include staff shortages and supply chain breakdowns and similar risks. The company will continue to monitor and where possible take action to avoid or mitigate the consequence of any such impacts on its portfolio.

The company believes that its investments benefit from a range of protective mechanisms to mitigate the consequences of adverse events. These include contractual and regulatory mechanisms together with project insurances.

However, the company notes that even where these mitigants apply they may not work in "real time" which might result in changes to the currently assumed profile and/or timing of cash receipts by the Company from specifically affected assets.

John Stares will retire from the Board with effect from 31 March 2020 and, as previously announced, John Whittle will retire from the Board at the 2020 AGM.

The company noted that its final results for the year ending 31 December 2019 have been postponed due to the request by the Financial Conduct Authority and the Financial Reporting Council for all listed companies to delay the issuance of preliminary results for at least two weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Avalon Furniture is recalling about 9,500 units of Cottage Town Bedroom Furniture collection sold through Rooms To Go due to violation of federal lead paint ban, the U.S. Consumer Product Safety Commission said in a statement. According to the agency, the base coat paint used on pieces within the furniture collection contains levels of lead that exceed the federal lead paint standard. Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Phase 3 trial of arthritis drug Kevzara (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints. In the trial, Kevzara was added to best supportive care compared to best supportive care alone (placebo). The companies have stopped the U.S. trial. Shares of Moderna Inc. (MRNA) slipped over 5% on Thursday after a report claimed that the biotechnology company's late-stage trial for a coronavirus vaccine will be delayed. Moderna is developing mRNA-1273 in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The...
RELATED NEWS
Follow RTT